Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

NCT01216371 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma
Pulmonary Metastases

Interventions

DRUG: Sunitinib
DRUG: Placebo

Sponsor

Association of Urologic Oncology (AUO)

Collaborators

[object Object]